Clinical response to bevacizumab in schwannomatosis.

Jaishri Blakeley; Karisa C Schreck; D Gareth Evans; Bruce R Korf; David Zagzag; Matthias A Karajannis; Amanda L Bergner; Allan J Belzberg

doi:10.1212/WNL.0000000000000997

Clinical response to bevacizumab in schwannomatosis.

Jaishri Blakeley
, Karisa C Schreck
, D Gareth Evans
, Bruce R Korf
, David Zagzag
, Matthias A Karajannis
, Amanda L Bergner
, Allan J Belzberg

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Neurology
DOIs	https://doi.org/10.1212/WNL.0000000000000997
Publication status	Published - 22 Oct 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1212/WNL.0000000000000997

Cite this

@article{254420bbeec94d4fbaa7e095b35bddfb,

title = "Clinical response to bevacizumab in schwannomatosis.",

author = "Jaishri Blakeley and Schreck, \{Karisa C\} and Evans, \{D Gareth\} and Korf, \{Bruce R\} and David Zagzag and Karajannis, \{Matthias A\} and Bergner, \{Amanda L\} and Belzberg, \{Allan J\}",

year = "2014",

month = oct,

day = "22",

doi = "10.1212/WNL.0000000000000997",

language = "English",

journal = "Neurology",

issn = "1526-632X",

publisher = "Lippincott Williams \& Wilkins",

}

TY - JOUR

T1 - Clinical response to bevacizumab in schwannomatosis.

AU - Blakeley, Jaishri

AU - Schreck, Karisa C

AU - Evans, D Gareth

AU - Korf, Bruce R

AU - Zagzag, David

AU - Karajannis, Matthias A

AU - Bergner, Amanda L

AU - Belzberg, Allan J

PY - 2014/10/22

Y1 - 2014/10/22

U2 - 10.1212/WNL.0000000000000997

DO - 10.1212/WNL.0000000000000997

M3 - Article

C2 - 25339217

SN - 1526-632X

JO - Neurology

JF - Neurology

ER -